Warsaw, Poland

Maciej Skarzynski

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Instytut Farmaceutyczny. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maciej Skarzynski. Retrieved from https://idiyas.com/inventor/maciej-skarzynski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maciej Skarzynski: Innovator in Pharmaceutical Processes

Introduction

Maciej Skarzynski is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of imatinib base. His innovative approach has streamlined the process, making it more efficient and accessible.

Latest Patents

Maciej Skarzynski holds a patent for a process for the preparation of imatinib base. This improved method involves several steps, including the reaction of 2-methyl-5-nitroaniline with cyanamide, leading to the formation of various intermediates. The process ultimately results in the isolation of imatinib base, utilizing simple starting materials while avoiding laborious isolation and purification steps. This innovation facilitates scale-up for pharmaceutical production.

Career Highlights

Maciej Skarzynski is associated with the Instytut Farmaceutyczny, where he has been instrumental in advancing pharmaceutical research. His work has not only contributed to the development of new drugs but has also enhanced existing processes in the industry.

Collaborations

Throughout his career, Maciej has collaborated with notable colleagues, including Wojciech Szczepek and Wojciech Luniewski. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Maciej Skarzynski's contributions to the pharmaceutical industry through his innovative processes exemplify the importance of research and development in creating effective medications. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…